School of Medicine

The Washington University School of Medicine is one of nine U.S. academic institutions selected by the American Society of Hematology for the organization’s Hematology-Focused Fellowship Training Program. Applications open in July.

The St. Louis Business Journal has recognized Anthony T. Dao, MD, an instructor in the Division of Hospital Medicine at the School of Medicine, with a Business of Pride Award.

A new study from Washington University School of Medicine found that the fiber byproducts of food production may be an untapped source of beneficial biomolecules that contribute to human health.

The School of Medicine has received $50,000 from Healthy Blue Missouri to support The SPOT (Supporting Positive Opportunities with Teens) at Jennings Senior High School.

The Organization for Human Brain Mapping has awarded its Glass Brain Award to Deanna Barch, of Arts & Sciences and the School of Medicine, in recognition of her influential work on the function of the human brain.

A community-based rehabilitation program may be an effective way to provide services to people with disabilities even in places with conflict such as Afghanistan, finds a new study from the Brown School and the School of Medicine at Washington University.

Brendan Heiden, MD, a surgical resident and cardiothoracic surgery research fellow at Washington University School of Medicine, received the Harborside Endowed Merit Award from Conquer Cancer, the foundation of the American Society of Clinical Oncology.

A mouse study led by Washington University School of Medicine suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

Researchers at Washington University School of Medicine have found that although there have been steady increases in the number of people nationwide who die by suicide, such increases have slowed in states that have implemented Medicaid expansion.

A study from the Washington University School of Medicine shows that treatment with the immunity boosting protein interleukin 7 (IL-7) after an infusion of genetically modified T cells causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells.